Advertisement
The Journal of Heart and Lung Transplantation
International Society for Heart and Lung Transplantation.

L-alanyl-L-glutamine modified perfusate improves human lung cell functions and extend porcine ex vivo lung perfusion

Published:November 03, 2022DOI:https://doi.org/10.1016/j.healun.2022.10.022

      Background

      The clinical application of normothermic ex vivo lung perfusion (EVLP) has increased donor lung utilization for transplantation through functional assessment. To develop it as a platform for donor lung repair, reconditioning and regeneration, the perfusate should be modified to support the lung during extended EVLP.

      Methods

      Human lung epithelial cells and pulmonary microvascular endothelial cells were cultured, and the effects of Steen solution (commonly used EVLP perfusate) on basic cellular function were tested. Steen solution was modified based on screening tests in cell culture, and further tested with an EVLP cell culture model, on apoptosis, GSH, HSP70, and IL-8 expression. Finally, a modified formula was tested on porcine EVLP. Physiological parameters of lung function, histology of lung tissue, and amino acid concentrations in EVLP perfusate were measured.

      Results

      Steen solution reduced cell confluence, induced apoptosis, and inhibited cell migration, compared to regular cell culture media. Adding L-alanyl-L-glutamine to Steen solution improved cell migration and decreased apoptosis. It also reduced cold preservation and warm perfusion-induced apoptosis, enhanced GSH and HSP70 production, and inhibited IL-8 expression on an EVLP cell culture model. L-alanyl-L-glutamine modified Steen solution supported porcine lungs on EVLP with significantly improved lung function, well-preserved histological structure, and significantly higher levels of multiple amino acids in EVLP perfusate.

      Conclusions

      Adding L-alanyl-L-glutamine to perfusate may provide additional energy support, antioxidant, and cytoprotective effects to lung tissue. The pipeline developed herein, with cell culture, cell EVLP, and porcine EVLP models, can be used to further optimize perfusates to improve EVLP outcomes.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Heart and Lung Transplantation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Klein AS
        • Messersmith EE
        • Ratner LE
        • Kochik R
        • Baliga PK
        • Ojo AO
        Organ donation and utilization in the United States, 1999-2008.
        Am J Transplant. 2010; 10: 973-986
        • Valapour M
        • Lehr CJ
        • Skeans MA
        • et al.
        OPTN/SRTR 2019 Annual Data Report: lung.
        Am J Transplant. 2021; 21: 441-520
        • Lund LH
        • Khush KK
        • Cherikh WS
        • et al.
        The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: allograft ischemic time.
        J Heart Lung Transplant. 2017; 36: 1037-1046
        • Ali A
        • Cypel M
        Ex-vivo lung perfusion and ventilation: where to from here?.
        Curr Opin Organ Transplant. 2019; 24: 297-304
        • Cypel M
        • Yeung JC
        • Liu M
        • et al.
        Normothermic ex vivo lung perfusion in clinical lung transplantation.
        N Engl J Med. 2011; 364: 1431-1440
        • Tikkanen JM
        • Cypel M
        • Machuca TN
        • et al.
        Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation.
        J Heart Lung Transplant. 2015; 34: 547-556
        • Senior M
        Beating the organ clock.
        Nat Biotechnol. 2018; 36: 488-492
        • Shin J
        • Hsin MK
        • Baciu C
        • et al.
        Use of metabolomics to identify strategies to improve and prolong ex vivo lung perfusion for lung transplants.
        J Heart Lung Transplant. 2021; 40: 525-535
        • Buchko MT
        • Stewart CJ
        • Hatami S
        • Himmat S
        • Freed DH
        • Nagendran J
        Total parenteral nutrition in ex vivo lung perfusion: addressing metabolism improves both inflammation and oxygenation.
        Am J Transplant. 2019; 19: 3390-3397
        • Takahashi M
        • Andrew Cheung HY
        • Watanabe T
        • et al.
        Strategies to prolong homeostasis of ex vivo perfused lungs.
        J Thorac Cardiovasc Surg. 2021; 161: 1963-1973
        • Krump-Konvalinkova V
        • Bittinger F
        • Unger RE
        • Peters K
        • Lehr HA
        • Kirkpatrick CJ
        Generation of human pulmonary microvascular endothelial cell lines.
        Lab Invest. 2001; 81: 1717-1727
        • Cardella JA
        • Keshavjee S
        • Mourgeon E
        • et al.
        A novel cell culture model for studying ischemia-reperfusion injury in lung transplantation.
        J Appl Physiol (1985). 2000; 89: 1553-1560
        • Gao W
        • Zhao J
        • Kim H
        • et al.
        α1-Antitrypsin inhibits ischemia reperfusion-induced lung injury by reducing inflammatory response and cell death.
        J Heart Lung Transplant. 2014; 33: 309-315
        • Kim H
        • Zhao J
        • Zhang Q
        • et al.
        δV1-1 Reduces pulmonary ischemia reperfusion-induced lung injury by inhibiting necrosis and mitochondrial localization of PKCδ and p53.
        Am J Transplant. 2016; 16: 83-98
        • Casiraghi M
        • Tatreau JR
        • Abano JB
        • et al.
        In vitro modeling of nonhypoxic cold ischemia-reperfusion simulating lung transplantation.
        J Thorac Cardiovasc Surg. 2009; 138: 760-767
        • Cypel M
        • Yeung JC
        • Hirayama S
        • et al.
        Technique for prolonged normothermic ex vivo lung perfusion.
        J Heart Lung Transplant. 2008; 27: 1319-1325
        • Lin H
        • Chen M
        • Tian F
        • et al.
        α-Anti-trypsin improves function of porcine donor lungs during ex-vivo lung perfusion.
        J Heart Lung Transplant. 2018; 37: 656-666
        • Mordant P
        • Nakajima D
        • Kalaf R
        • et al.
        Mesenchymal stem cell treatment is associated with decreased perfusate concentration of interleukin-8 during ex vivo perfusion of donor lungs after 18-hour preservation.
        J Heart Lung Transplant. 2016; 35: 1245-1254
        • Lai CC
        • Liu WL
        • Chen CM
        Glutamine attenuates acute lung injury caused by acid aspiration.
        Nutrients. 2014; 6: 3101-3116
        • Zhang F
        • Wang X
        • Pan L
        • Wang W
        • Li N
        • Li J
        Glutamine attenuates lipopolysaccharide-induced acute lung injury.
        Nutrition. 2009; 25: 692-698
        • Hou YC
        • Chiu WC
        • Yeh CL
        • Yeh SL
        Glutamine modulates lipopolysaccharide-induced activation of NF-κB via the Akt/mTOR pathway in lung epithelial cells.
        Am J Physiol Lung Cell Mol Physiol. 2012; 302: L174-L183
        • Peng CK
        • Huang KL
        • Wu CP
        • et al.
        Glutamine protects ischemia-reperfusion induced acute lung injury in isolated rat lungs.
        Pulm Pharmacol Ther. 2011; 24: 153-161
        • Singleton KD
        • Serkova N
        • Beckey VE
        • Wischmeyer PE
        Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression.
        Crit Care Med. 2005; 33: 1206-1213
        • Singleton KD
        • Wischmeyer PE
        Glutamine’s protection against sepsis and lung injury is dependent on heat shock protein 70 expression.
        Am J Physiol Regul Integr Comp Physiol. 2007; 292: R1839-R1845
        • O'Sullivan MJ
        • Hirota N
        • Martin JG
        Sphingosine 1-phosphate (S1P) induced interleukin-8 (IL-8) release is mediated by S1P receptor 2 and nuclear factor κB in BEAS-2B cells.
        PLoS One. 2014; 9: e95566
        • Iske J
        • Hinze CA
        • Salman J
        • Haverich A
        • Tullius SG
        • Ius F
        The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury.
        Am J Transplant. 2021; 21: 3831-3839
        • Pagano F
        • Nocella C
        • Sciarretta S
        • et al.
        Cytoprotective and antioxidant effects of steen solution on human lung spheroids and human endothelial cells.
        Am J Transplant. 2017; 17: 1885-1894
        • Emaminia A
        • Lapar DJ
        • Zhao Y
        • et al.
        Adenosine A₂A agonist improves lung function during ex vivo lung perfusion.
        Ann Thorac Surg. 2011; 92: 1840-1846
        • Dong B
        • Stewart PW
        • Egan TM
        Postmortem and ex vivo carbon monoxide ventilation reduces injury in rat lungs transplanted from non-heart-beating donors.
        J Thorac Cardiovasc Surg. 2013; 146: 429-436
        • Dong BM
        • Abano JB
        • Egan TM
        Nitric oxide ventilation of rat lungs from non-heart-beating donors improves posttransplant function.
        Am J Transplant. 2009; 9: 2707-2715
        • Noda K
        • Shigemura N
        • Tanaka Y
        • et al.
        Hydrogen preconditioning during ex vivo lung perfusion improves the quality of lung grafts in rats.
        Transplantation. 2014; 98: 499-506
        • Galasso M
        • Feld JJ
        • Watanabe Y
        • et al.
        Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion.
        Nat Commun. 2019; 10: 481
        • Inci I
        • Hillinger S
        • Arni S
        • Kaplan T
        • Inci D
        • Weder W
        Reconditioning of an injured lung graft with intrabronchial surfactant instillation in an ex vivo lung perfusion system followed by transplantation.
        J Surg Res. 2013; 184: 1143-1149
        • Khalifé-Hocquemiller T
        • Sage E
        • Dorfmuller P
        • et al.
        Exogenous surfactant attenuates lung injury from gastric-acid aspiration during ex vivo reconditioning in pigs.
        Transplantation. 2014; 97: 413-418
        • Nakajima D
        • Liu M
        • Ohsumi A
        • et al.
        Lung lavage and surfactant replacement during ex vivo lung perfusion for treatment of gastric acid aspiration-induced donor lung injury.
        J Heart Lung Transplant. 2017; 36: 577-585
        • Cypel M
        • Liu M
        • Rubacha M
        • et al.
        Functional repair of human donor lungs by IL-10 gene therapy.
        Sci Transl Med. 2009; 1: 4ra9
        • Machuca TN
        • Cypel M
        • Bonato R
        • et al.
        Safety and efficacy of ex vivo donor lung adenoviral IL-10 gene therapy in a large animal lung transplant survival model.
        Hum Gene Ther. 2017; 28: 757-765
        • Lee JW
        • Krasnodembskaya A
        • McKenna DH
        • Song Y
        • Abbott J
        • Matthay MA
        Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria.
        Am J Respir Crit Care Med. 2013; 187: 751-760
        • Nakajima D
        • Watanabe Y
        • Ohsumi A
        • et al.
        Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation.
        J Heart Lung Transplant. 2019; 38: 1214-1223
        • Nykänen AI
        • Mariscal A
        • Duong A
        • et al.
        Engineered mesenchymal stromal cell therapy during human lung lung perfusion is compromised by acidic lung microenvironment.
        Mol Ther Methods Clin Dev. 2021; 23: 184-197
        • Loor G
        • Howard BT
        • Spratt JR
        • et al.
        Prolonged EVLP using OCS lung: cellular and acellular perfusates.
        Transplantation. 2017; 101: 2303-2311
        • Dromparis P
        • Aboelnazar NS
        • Wagner S
        • et al.
        Ex vivo perfusion induces a time- and perfusate-dependent molecular repair response in explanted porcine lungs.
        Am J Transplant. 2019; 19: 1024-1036
        • Becker S
        • Steinmeyer J
        • Avsar M
        • et al.
        Evaluating acellular versus cellular perfusate composition during prolonged ex vivo lung perfusion after initial cold ischaemia for 24 hours.
        Transpl Int. 2016; 29: 88-97
        • Goldaracena N
        • Echeverri J
        • Spetzler VN
        • et al.
        Anti-inflammatory signaling during ex vivo liver perfusion improves the preservation of pig liver grafts before transplantation.
        Liver Transpl. 2016; 22: 1573-1583
        • Kaths JM
        • Cen JY
        • Chun YM
        • et al.
        Continuous normothermic ex vivo kidney perfusion is superior to brief normothermic perfusion following static cold storage in donation after circulatory death pig kidney transplantation.
        Am J Transplant. 2017; 17: 957-969
        • Saren G
        • Wong A
        • Lu Y-B
        • et al.
        Ischemia-reperfusion injury in a simulated lung transplant setting differentially regulates transcriptomic profiles between human lung endothelial and epithelial cells.
        Cells. 2021; 102713https://doi.org/10.3390/cells10102713
        • Liu M
        • Tanswell AK
        • Post M
        Mechanical force-induced signal transduction in lung cells.
        Am J Physiol. 1999; 277: L667-LL83
        • Chatterjee S
        • Nieman GF
        • Christie JD
        • Fisher AB
        Shear stress-related mechanosignaling with lung ischemia: lessons from basic research can inform lung transplantation.
        Am J Physiol Lung Cell Mol Physiol. 2014; 307: L668-LL80